Earnings History Data for Vir Biotechnology, Inc. (VIR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vir Biotechnology, Inc.

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	AH		VIR	Vir Biotechnology, Inc.	1,040	-1.56	-0.96	-1.22	Vir Biotechnology GAAP EPS of -$1.56 misses by $0.60, revenue of $2.38M misses by $3.13M [10/31/2024 4:05 PM]	9.26	1.77 (23.63%)	7.18	-0.31 (-4.14%)	7.12 - 13.09	6,572,968	930,000	1,437
Vir Biotechnology GAAP EPS of -$1.56 misses by $0.60, revenue of $2.38M misses by $3.13M [10/31/2024 4:05 PM] Vir Biotechnology Q3 2024 Earnings Preview [11/1/2024 1:44 PM] Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update [2024-10-31 04:05PM] U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners [2024-11-01 12:04AM] Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates [Oct-31-24 05:20PM]
01-08-2024	AH		VIR	Vir Biotechnology, Inc.	1,380	-1.02	-0.93	-1.45	Vir Biotechnology GAAP EPS of -$1.02 misses by $0.06, revenue of $3.07M misses by $4.43M [8/1/2024 4:44 PM]	9.24	-0.49 (-5.04%)	9.26	-0.47 (-4.83%)	7.61 - 14.27	842,738	750,000	12,221
Vir Biotechnology GAAP EPS of -$1.02 misses by $0.06, revenue of $3.07M misses by $4.43M [8/1/2024 4:44 PM] Vir announces major restructuring, licensing deal with Sanofi [8/1/2024 5:27 PM]
02-05-2024	AH		VIR	Vir Biotechnology, Inc.	1,130	-0.48	-0.99	-1.06	Vir Biotechnology GAAP EPS of -$0.48 beats by $0.59, revenue of $56.38M beats by $44.67M [5/2/2024 4:25 PM]	10.46	1.28 (13.89%)	10.01	0.83 (9.04%)	7.61 - 27.48	1,375,132	1,020,000	8,319
Vir Biotechnology GAAP EPS of -$0.48 beats by $0.59, revenue of $56.38M beats by $44.67M [5/2/2024 4:25 PM]
22-02-2024	AH		VIR	Vir Biotechnology, Inc.	1,380	-0.86	-1.14	-0.76	Vir Biotechnology GAAP EPS of -$0.86 beats by $0.15, revenue of $16.79M beats by $10.24M [2/22/2024 4:27 PM]	11.52	1.21 (11.80%)	10.50	0.20 (1.94%)	7.72 - 27.48	1,569,974	1,210,000	244
Vir Biotechnology GAAP EPS of -$0.86 beats by $0.15, revenue of $16.79M beats by $10.24M [2/22/2024 4:27 PM]
02-11-2023	AH		VIR	Vir Biotechnology, Inc.	1,060	-1.22	-1.21	1.30	Vir Biotechnology GAAP EPS of -$1.22 beats by $0.03, revenue of $2.6M misses by $6.17M [11/2/2023 4:33 PM]	8.77	0.58 (7.02%)	8.00	-0.19 (-2.32%)	7.72 - 31.55	1,806,361	1,210,000	29,973
Vir Biotechnology GAAP EPS of -$1.22 beats by $0.03, revenue of $2.6M misses by $6.17M [11/2/2023 4:33 PM]
03-08-2023	AH		VIR	Vir Biotechnology, Inc.	1,910	-1.45	-1.21	-0.58	Vir BiotechnologyEPS of -$1.45, revenue of $3.8M misses by $18.59M [8/3/2023 4:09 PM]	13.63	-0.34 (-2.43%)	13.97	0.0 (0.00%)	12.56 - 31.55	1,103,688	1,630,000	2,010
Vir BiotechnologyEPS of -$1.45, revenue of $3.8M misses by $18.59M [8/3/2023 4:09 PM]
23-02-2023	AH	4:00 PM ET (Feb 23)	VIR	Vir Biotechnology, Inc.	3,430	-0.76	-0.04	3.92	Vir Biotechnology GAAP EPS of -$0.76 misses by $0.42, revenue of $49.4M misses by $84.84M [2/23/2023 4:07 PM]	23.00	-2.80 (-10.87%)	24.72	-1.09 (-4.22%)	18.05 - 31.78	2,773,123	1,140,000	143,470
Vir Biotechnology GAAP EPS of -$0.76 misses by $0.42, revenue of $49.4M misses by $84.84M [2/23/2023 4:07 PM] Vir Biotechnology loses 5% following Q4 2022 earnings misses [2/23/2023 8:37 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	VIR	Vir Biotechnology, Inc.	2,990	1.30	0.06	0.82	Vir Biotechnology GAAP EPS of $1.30 beats by $1.37, revenue of $374.6M beats by $260.32M [11/3/2022 4:07 PM]	25.53	3.73 (17.11%)	24.00	2.20 (10.09%)	18.05 - 58.00	1,645,635	690,000	5,689
Vir Biotechnology GAAP EPS of $1.30 beats by $1.37, revenue of $374.6M beats by $260.32M [11/3/2022 4:07 PM] Vir Biotechnology rises after hours as GSK collaboration revenue leads to big Q3 beat [11/3/2022 5:40 PM]
09-08-2022	AH	4:05 PM ET (Aug 4)	VIR	Vir Biotechnology	3,994	-0.58	-0.17	0.00	Vir Biotechnology GAAP EPS of -$0.58 misses by $0.84 [8/9/2022 4:04 PM]	30.64	1.81 (6.26%)	24.80	-4.04 (-14.01%)	18.21 - 58.00	2,284,804	750,000	13,272
Vir Biotechnology GAAP EPS of -$0.58 misses by $0.84 [8/9/2022 4:04 PM] Vir Biotechnology falls 15% on Q2 revenue miss impacted by ~$400M for potential write-offs [8/9/2022 6:38 PM]
05-05-2022	AH	4:00 PM ET (May 5)	VIR	Vir Biotechnology, Inc.	2,760	3.85	3.21	-1.32	Vir Biotechnology GAAP EPS of $3.85 beats by $0.31, revenue of $1.23B beats by $418.95M [5/5/2022 4:48 PM]	21.58	0.74 (3.55%)	21.58	0.0 (0.00%)	19.44 - 58.00	1,608,677	960,000	813
Vir Biotechnology GAAP EPS of $3.85 beats by $0.31, revenue of $1.23B beats by $418.95M [5/5/2022 4:48 PM] Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More [May-04-22 03:19PM] Vir Biotechnology (NASDAQ:VIR) shareholders are up 4.2% this past week, but still in the red over the last year [May-05-22 01:00PM] Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results [May-05-22 04:07PM] Vir Biotechnology, Inc. (VIR) Q1 Earnings and Revenues Beat Estimates [May-05-22 05:25PM]
24-02-2022	AH	4:05 PM ET (Feb 24)	VIR	Vir Biotechnology, Inc.	3,860	3.92	2.60	-0.83	Vir Biotechnology GAAP EPS of $3.92 beats by $1.29, revenue of $812.7M beats by $189.8M [2/24/2022 4:22 PM]	27.05	-1.17 (-4.15%)	28.40	0.18 (0.64%)	24.91 - 73.29	595,910	970,000	2,478
GlaxoSmithKline-Vir's COVID therapy use limited by FDA - Reuters [2/24/2022 5:03 AM] Vir Biotechnology GAAP EPS of $3.92 beats by $1.29, revenue of $812.7M beats by $189.8M [2/24/2022 4:22 PM] Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-24-22 04:04PM] Vir Biotechnology, Inc. (VIR) Q4 Earnings and Revenues Beat Estimates [Feb-24-22 05:40PM] VIR Q4 Earnings Beat on Higher Revenues From Covid Treatment [Feb-25-22 12:49PM]
04-11-2021	AH	4:05 PM ET (Nov 4)	VIR	Vir Biotechnology, Inc.	4,830	0.82	-0.30	-0.67	Vir Biotechnology EPS beats by $0.74, misses on revenue [11/4/2021 4:48 PM]	31.22	-5.46 (-14.89%)	33.20	-3.48 (-9.49%)	25.31 - 141.01	2,325,423	600,000	67,584
Vir Biotechnology EPS beats by $0.74, misses on revenue [11/4/2021 4:48 PM] Regeneron, Eli Lilly join selloff as Pfizer hopes for a COVID-19 pill [11/5/2021 11:14 AM] Section 32 Raises $740 Million Venture Fund [Nov-04-21 08:14AM] Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-04-21 04:05PM] Vir Biotechnology, Inc. (VIR) Beats Q3 Earnings and Revenue Estimates [Nov-04-21 06:35PM] Why Vir Biotechnology Stock Is Sliding Today [Nov-05-21 03:03PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	VIR	Vir Biotechnology, Inc.	4,540	0.46	-0.68	-0.27	Vir Biotechnology reports Q2 results [8/5/2021 4:17 PM]	38.42	0.71 (1.88%)	40.50	2.79 (7.40%)	25.31 - 141.01	673,391	860,000	8,724
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results [Aug-05-21 04:05PM] Vir Biotechnology, Inc. (VIR) Q2 Earnings and Revenues Beat Estimates [Aug-05-21 05:25PM]
06-05-2021	AH	4:00 PM ET (May 6)	VIR	Vir Biotechnology, Inc.	5,780	-1.32	-0.58	-0.71	Vir Biotechnology EPS misses by $1.31, misses on revenue [5/6/2021 4:17 PM]	42.97	1.36 (3.27%)	42.97	0.0 (0.00%)	25.31 - 141.01	511,765	610,000	7,152
Vir Biotechnology EPS misses by $1.31, misses on revenue [5/6/2021 4:17 PM] Vir Biotechnology Q1 loss widens as R&D spend ramps [5/6/2021 5:10 PM] EMA initiates rolling review of GSK, Vir Bio's sotrovimab for early treatment of COVID-19 [5/7/2021 6:02 AM] Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results [May-06-21 04:05PM] Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Misses Revenue Estimates [May-06-21 07:35PM] GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19 [May-07-21 05:53AM]
25-02-2021	AH	4:00 PM ET (Feb 25)	VIR	Vir Biotechnology, Inc.	8,130	-0.83	-0.72	-0.71	Vir Biotechnology EPS misses by $0.11, misses on revenue [2/25/2021 4:08 PM]	63.01	-1.10 (-1.72%)	63.00	-1.11 (-1.73%)	23.26 - 141.01	772,783	1,101,857	7,284
Vir Biotechnology EPS misses by $0.11, misses on revenue [2/25/2021 4:08 PM]
10-11-2020	AH	4:00 PM ET (Nov 10)	VIR	Vir Biotechnology, Inc.	3,980	-0.67	-0.57	-4.60	Vir Biotechnology EPS misses by $0.08, misses on revenue [11/10/2020 4:04 PM]	27.58	1.74 (6.75%)	25.80	-0.04 (-0.15%)	11.65 - 75.00	1,090,446	1,128,769	4,089

11-08-2020	AH	4:00 PM ET (Aug 11)	VIR	Vir Biotechnology, Inc.	6,570	-0.27	-0.62	0.00	Vir Biotechnology EPS beats by $0.35, beats on revenue [8/11/2020 4:08 PM]	52.14	-0.52 (-0.99%)	52.80	0.14 (0.27%)	11.65 - 75.00	509,701	671,077	2,444

12-05-2020	AH	Before the open (May 12)	VIR	Vir Biotechnology, Inc.	3,580	-0.71	-0.48	0.00	Vir Biotechnology EPS misses by $0.23, beats on revenue [5/12/2020 4:23 PM]	30.71	0.45 (1.49%)	30.90	0.19 (0.62%)	11.65 - 75.00	1,096,851	915,800	4,758